Work

A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

Year: 2009

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2009.02.007

Authors: Kathleen M. Schmeler, Saroj Vadhan-Raj, Pedro T. Ramirez, Sachin M. Apte, Lorenzo Cohen, Roland L. Bassett, Revathy B. Iyer, Judith K. Wolf, Charles L. Levenback, David M. Gershenson, Ralph S. Freedman

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Bayer HealthCare, National Cancer Institute

Awards: G111615301, G2246080663

OpenAlex ID: W2170465167

FWCI: 6.946

Cites: 35

Cited by: 48

Related to: 10